The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Characterization of Interleukin-1 Receptor-associated Kinase in Normal and Endotoxin-tolerant Cells
Open accessAbstract
Interleukin-1 receptor-associated kinase (IRAK), a signal transducer for interleukin-1, has also been suggested to participate in the Toll-like receptor-mediated innate immune response to bacterial endotoxin lipopolysaccharide (LPS). Using the human promonocytic THP-1 cell line, we demonstrated that the endogenous IRAK is quickly activated in response to bacterial LPS stimulation, as measured by its in vitro kinase activity toward myelin basic protein. LPS also triggers the association of IRAK with MyD88, the adaptor protein linking IRAK to the Toll-like receptor/interleukin-1beta receptor intracellular domain. Macrophage cells with prolonged LPS treatment become tolerant to additional dose of LPS and no longer express inflammatory cytokines. Endotoxin tolerance is a common phenomenon observed in blood from sepsis patients. We observed for the first time that the quantity of IRAK is greatly reduced in LPS-tolerant THP-1 cells, and its activity no longer responds to further LPS challenge. In addition, IRAK does not associate with MyD88 in the tolerant cells. Furthermore, application of AG126, a putative tyrosine kinase inhibitor, can substantially alleviate the LPS-induced cytokine gene expression and can also decrease IRAK level and activity. Our study indicates that IRAK is essential for LPS-mediated signaling and that cells may develop endotoxin tolerance by down-regulating IRAK.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hoshino, K., Takeuchi, O., Kawai, T., Sanjo, H., Ogawa, T., Takeda, Y., Takeda, K., & Akira, S. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.162.7.3749 · Cited by 3,374
Cited by
Toll-like receptors in innate immunity
Takeda, K. (2004) · International Immunology · doi:10.1093/intimm/dxh186 · Cited by 3,328
Muscle as an Endocrine Organ: Focus on Muscle-Derived Interleukin-6
Pedersen, B. K., & Febbraio, M. A. (2008) · Physiological Reviews · doi:10.1152/physrev.90100.2007 · Cited by 2,388
LPS induction of gene expression in human monocytes
Guha, M., & Mackman, N. (2001) · Cellular Signalling · doi:10.1016/s0898-6568(00)00149-2 · Cited by 2,304
Toll-like receptors and innate immunity
Kumar, H., Kawai, T., & Akira, S. (2009) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2009.08.062 · Cited by 1,173
Rapid Secretion of Interleukin-1β by Microvesicle Shedding
MacKenzie, A., Wilson, H. L., Kiss-Toth, E., Dower, S. K., North, R. A., & Surprenant, A. (2001) · Immunity · doi:10.1016/s1074-7613(01)00229-1 · Cited by 863
miR-146a is a significant brake on autoimmunity, myeloproliferation, and cancer in mice
Boldin, M. P., Taganov, K. D., Rao, D. S., Yang, L., Zhao, J. L., Kalwani, M., Garcia-Flores, Y., Luong, M., Devrekanli, A., Xu, J., et al. (2011) · Journal of Experimental Medicine · doi:10.1084/jem.20101823 · Cited by 861
Abreu, M. T., Vora, P., Faure, E., Thomas, L. S., Arnold, E. T., & Arditi, M. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.167.3.1609 · Cited by 680
Fujihara, M., Muroi, M., Tanamoto, K.-I., Suzuki, T., Azuma, H., & Ikeda, H. (2003) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2003.08.003 · Cited by 574
Toll receptors, CD14, and macrophage activation and deactivation by LPS
Dobrovolskaia, M. A., & Vogel, S. N. (2002) · Microbes and Infection · doi:10.1016/s1286-4579(02)01613-1 · Cited by 564
TLR-signaling Networks: An Integration of Adaptor Molecules, Kinases, and Cross-talk
Brown, J., Wang, H., Hajishengallis, G. N., & Martin, M. (2011) · Journal of Dental Research · doi:10.1177/0022034510381264 · Cited by 534
West, M. A., & Heagy, W. (2002) · Critical Care Medicine · doi:10.1097/00003246-200201001-00009 · Cited by 520
Otte, J.-M., Cario, E., & Podolsky, D. K. (2004) · Gastroenterology · doi:10.1053/j.gastro.2004.01.007 · Cited by 505
Toll-like Receptors and Innate Immunity
(2001) · Advances in Immunology · doi:10.1016/s0065-2776(01)78001-7 · Cited by 496
miR-146a Is Critical for Endotoxin-induced Tolerance
Nahid, M. A., Pauley, K. M., Satoh, M., & Chan, E. K. L. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.056317 · Cited by 423
Synergy and Cross-Tolerance Between Toll-Like Receptor (TLR) 2- and TLR4-Mediated Signaling Pathways
Sato, S., Nomura, F., Kawai, T., Takeuchi, O., Mühlradt, P. F., Takeda, K., & Akira, S. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.12.7096 · Cited by 401
Triad3A, an E3 ubiquitin-protein ligase regulating Toll-like receptors
Chuang, T.-H., & Ulevitch, R. J. (2004) · Nature Immunology · doi:10.1038/ni1066 · Cited by 374
MicroRNAs and Immunity: Tiny Players in a Big Field
Taganov, K. D., Boldin, M. P., & Baltimore, D. (2007) · Immunity · doi:10.1016/j.immuni.2007.02.005 · Cited by 343
Mechanisms of bacterial lipopolysaccharide-induced endothelial apoptosis
Bannerman, D. D., & Goldblum, S. E. (2003) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00338.2002 · Cited by 334
Sirtuins Link Inflammation and Metabolism
Vachharajani, V. T., Liu, T., Wang, X., Hoth, J. J., Yoza, B. K., & McCall, C. E. (2016) · Journal of Immunology Research · doi:10.1155/2016/8167273 · Cited by 320
Self-citationMechanisms of deoxynivalenol-induced gene expression and apoptosis
Pestka, J. J. (2008) · Food Additives & Contaminants: Part A · doi:10.1080/02652030802056626 · Cited by 308
Dobrovolskaia, M. A., Medvedev, A. E., Thomas, K. E., Cuesta, N., Toshchakov, V., Ren, T., Cody, M. J., Michalek, S. M., Rice, N. R., & Vogel, S. N. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.170.1.508 · Cited by 300
MicroRNA in TLR signaling and endotoxin tolerance
Nahid, M. A., Satoh, M., & Chan, E. K. (2011) · Cellular & Molecular Immunology · doi:10.1038/cmi.2011.26 · Cited by 294
Lehner, M. D., Morath, S., Michelsen, K. S., Schumann, R. R., & Hartung, T. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.8.5161 · Cited by 283
Kim, Y.-G., Park, J.-H., Shaw, M. H., Franchi, L., Inohara, N., & Núñez, G. (2008) · Immunity · doi:10.1016/j.immuni.2007.12.012 · Cited by 281
Medvedev, A. E., Lentschat, A., Wahl, L. M., Golenbock, D. T., & Vogel, S. N. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.169.9.5209 · Cited by 271
Chronic stimulation of Nod2 mediates tolerance to bacterial products
Hedl, M., Li, J., Cho, J. H., & Abraham, C. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0706097104 · Cited by 269
IRAK1: A critical signaling mediator of innate immunity
Gottipati, S., Rao, N. L., & Fung-Leung, W.-P. (2008) · Cellular Signalling · doi:10.1016/j.cellsig.2007.08.009 · Cited by 268
Review: Molecular mechanisms of endotoxin tolerance
Fan, H., & Cook, J. A. (2004) · Journal of Endotoxin Research · doi:10.1177/09680519040100020301 · Cited by 264
Innate Immune Programing by Endotoxin and Its Pathological Consequences
Morris, M. C., Gilliam, E. A., & Li, L. (2015) · Frontiers in Immunology · doi:10.3389/fimmu.2014.00680 · Cited by 224
Self-citationDimitriou, I. D., Clemenza, L., Scotter, A. J., Chen, G., Guerra, F. M., & Rottapel, R. (2008) · Immunological Reviews · doi:10.1111/j.1600-065x.2008.00659.x · Cited by 184
Characterization of Tollip protein upon Lipopolysaccharide challenge
Li, T. (2004) · Molecular Immunology · doi:10.1016/j.molimm.2004.03.009 · Cited by 85
Turzanski, J., Grundy, M., Russell, N. H., & Pallis, M. (2004) · Leukemia · doi:10.1038/sj.leu.2403457 · Cited by 51
Metadata
- Authors
- Li, L., Cousart, S., Hu, J., & McCall, C. E.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2000-07
- Volume
- 275
- Issue
- 30
- Pages
- 23340-23345
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2035217892
- Cited by
- 242
- References
- 1
- FWCI
- 6.98
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.